Thermo Fisher Scientific Noncontrolling interest transactions and other decreased by 57.1% to $39.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 13.3%, from $45.00M to $39.00M. Over 2 years (FY 2021 to FY 2024), Noncontrolling interest transactions and other shows an upward trend with a 80.6% CAGR.
lin_noncontrolling_interest_transactions_and_other| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$25.00M | -$9.00M | $79.00M | -$34.00M | $37.00M | -$32.00M | $20.00M | $4.00M | $18.00M | $14.00M | $110.00M | $35.00M | $67.00M | $0.00 | $45.00M | -$4.00M | $91.00M | $39.00M |
| QoQ Change | — | +64.0% | +977.8% | -143.0% | +208.8% | -186.5% | +162.5% | -80.0% | +350.0% | -22.2% | +685.7% | -68.2% | +91.4% | -100.0% | — | -108.9% | >999% | -57.1% |
| YoY Change | — | — | — | — | +248.0% | -255.6% | +158.8% | -89.2% | +156.3% | — | +450.0% | +775.0% | +272.2% | -100.0% | -59.1% | -106.0% | — | -13.3% |